Buprenorphine Treatment of Heroin Dependence (Detoxification and Maintenance) in a Private Practice Setting
- 2 April 2001
- journal article
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 20 (2) , 75-83
- https://doi.org/10.1300/j069v20n02_06
Abstract
At the conclusion of a 3-year demonstration project in a medical setting in which refusal to accept methadone was an inclusion criterion, 12 subjects were unable to detoxify from buprenorphine and remained adamant in their refusal to enroll in a MMTP. In order to study the feasibility of expanding opportunities for treatment previously unavailable to this under-served population of heroin addicts, these 12 subjects plus an additional 11 subjects (N = 23) were recruited for a 12 months trial of buprenorphine treatment conducted in an office-based setting on a fee-for-service basis. An additional cohort of 40 heroin dependent subjects were entered in a protocol for detoxification only. The findings demonstrate both feasibility and patient acceptance of office based fee-for-service buprenorphine treatment, supporting the need for (1) additional studies of this population and (2) changes in government regulations to reintroduce addiction treatment under physician auspices in private practice settings.Keywords
This publication has 6 references indexed in Scilit:
- A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid DependenceArchives of General Psychiatry, 1996
- Community Based Heroin Addicts Who Turn to Experimental Treatment Rather Than Conventional CareJournal of Addictive Diseases, 1995
- Including narcotic addiction treatment in an office-based practicePublished by American Medical Association (AMA) ,1995
- Buprenorphine versus Methadone Maintenance for Opioid DependenceJournal of Nervous & Mental Disease, 1993
- A controlled trial of buprenorphine treatment for opioid dependencePublished by American Medical Association (AMA) ,1992
- Buprenorphine responders: A diagnostic subgroup of heroin addicts?Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1991